Crestline Management’s Axogen AXGN Stock Holding History

Crestline Management’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-69,777	Closed	-$837K	–	230
2021 Q3	$1.1M	Buy	+69,777	New	+$1.25M	0.1%	127
2019 Q4	–	Sell	-20,000	Closed	-$250K	–	47
2019 Q3	$250K	Buy	+20,000	New	+$329K	0.04%	78

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Crestline Management's AXGN Position: Q4 2021 in Review

Crestline Management sold out of Axogen (AXGN) in Q4 2021, closing a stake of 69,777 shares — an estimated $837K sold.

Crestline Management first reported a position in AXGN in Q3 2019 and held it in 2 quarters. The position peaked at $1.1M in Q3 2021. 134 funds tracked by Wall St. Rank hold AXGN as of Q4 2021.

Crestline Management reported no remaining Axogen position as of Q4 2021 after selling out during the quarter.
Crestline Management sold 69,777 Axogen shares in Q4 2021, an estimated $837K.
Crestline Management first reported a position in Axogen in Q3 2019 and held it in 2 quarters.
Crestline Management's Axogen position peaked at $1.1M in Q3 2021.
134 funds tracked by Wall St. Rank held Axogen as of Q4 2021.

Based on Crestline Management's 13F filing for Q4 2021, filed 14 Feb 2022.